Dense Deposit Disease

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Celldex Therapeutics
1 program
1
CDX-1135Phase 11 trial
Active Trials
NCT01791686Terminated1Est. Mar 2014

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Celldex TherapeuticsCDX-1135

Clinical Trials (1)

Total enrollment: 1 patients across 1 trials

Clinical Trial of CDX-1135 in Pediatric and Adult Patients With Dense Deposit Disease

Start: Jan 2013Est. completion: Mar 20141 patients
Phase 1Terminated

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space